Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection

Journal of Infectious Diseases

Volumn 182, Issue 4, 2000, Pages 1029-1038

  Fischer, Julie E ^a   Johnson, Joyce E ^a   Johnson, Teresa R ^a   Graham, Barney S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INTERLEUKIN 4 ANTIBODY; MESSENGER RNA; NEUTRALIZING ANTIBODY; PERTUSSIS TOXIN; VIRUS ANTIGEN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; MORTALITY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

ANIMAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DISEASE PROGRESSION; FEMALE; IMMUNIZATION, PASSIVE; INTERLEUKIN-4; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED BALB C; PLAQUE ASSAY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SPLEEN; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; VIRULENCE FACTORS, BORDETELLA; WEIGHT LOSS;

EID: 0033800909     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315806     Document Type: Article

References (33)

1. Respiratory syncytial virus
2. Bronchiolitis-associated hospitalizations among US children, 1980-1996
3. Respiratory syncytial viral infection in infants with congenital heart disease
4. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia
5. Respiratory syncytial virus infection and the immunocompromised host
6. Neonatal respiratory syncytial virus infection
7. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus
8. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus
9. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology
10. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus
11. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
12. ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis
13. Properties of the B oligomer of pertussis toxin
14. Action of pertussigen (pertussis toxin) on serum IgE and on Fcε receptors on lymphocytes
15. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines
16. Enhancement of interleukin-4 production by pertussis toxin
17. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: Adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2, and CD28
18. Bordetella pertussis-specificTh1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: Comparison of the T cell cytokine profiles in infants and mice
19. Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge
20. Characterization of genetically inactivated pertussis toxin mutant candidates for a new vaccine against whooping cough
21. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children
22. A regulatory role for interleukin-4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines
23. B cell stimulatory factor (BSF-1): Production of a monoclonal antibody and molecular characterization
24. Reinfection of mice with respiratory syncytial virus
25. Primary respiratory syncytial virus infection in mice
26. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus
27. T cell genetic background determines default T helper phenotype development in vitro
28. + cells
29. Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: Association of viral persistence with egg granuloma formation
30. + cytotoxic T cell response and prolongs viral infection
31. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis
32. A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K-129G, is an effective mucosal adjuvant for intranasally delivered proteins
33. Pertussis vaccination and wheezing illnesses in young children: Prospective cohort study